Company intelligence / Profile preview

Ajinomoto

Chūō-ku, Tokyo, Japanajinomoto.com ↗
Ownership
Public · 2802
Employees
~30000
Development stage
Other
01

Overview

Ajinomoto operates globally as a leading provider of contract development and manufacturing services across small molecules, peptides/proteins, oligonucleotides, antibody-drug conjugates and gene therapies. The company leverages over a century of expertise in amino acid fermentation and advanced bioprocessing technologies. It does not report its own clinical results but enables clients’ programs from pre-clinical through commercial stages using innovative platforms like AJIPHASE®, CORYNEX®, and AJICAP®. Its pharmaceutical-grade amino acids are widely used in cell culture media/excipients/APIs including key drugs such as levodopa.

Therapeutic areas
Rare DiseasesMetabolic DisordersNeurologyOncologyOther
Modalities
Small moleculePeptidesOligonucleotide drugs (Oligonucleotides)Antibody-drug conjugateProteinAmino acidsGene therapyRecombinant protein
Industry
Contract Manufacturing Organization
02

Partnerships

General Foods Corp. alliance for food productsDanone partnership historically on dairy productsNumerous undisclosed partnerships with global pharma/biotech companies via CDMO business
03

Financials

Market cap
$25.8B
Total revenue
$10B
Enterprise value
$28.1B

Beyond the preview

Go deeper on Ajinomoto.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ajinomoto.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call